Upcoming Event
|
11:20 AM ET |
Deutsche Bank's 38th Annual Health Care Conference
|
Archived Events
|
2:00 PM ET |
UBS Global Healthcare Conference 2013
|
||
|
2:20 PM PT |
Bank of America Merrill Lynch 2013 Health Care Conference
|
||
|
4:30 PM ET |
Cadence Pharmaceuticals 1st Quarter 2013 Earnings Release
|
||
|
5:30 AM PT |
Cadence Pharmaceuticals 4th Quarter 2012 Earnings Release
|
||
|
11:20 AM ET |
Cowen & Company 33rd Annual Health Care Conference
|
||
|
3:30 PM ET |
Leerink Swann Global Healthcare Conference
|
||
|
9:00 AM ET |
Cadence Pharmaceuticals Analyst and Investor Day
|
||
|
10:30 AM ET |
Piper Jaffray 24th Annual Healthcare Conference
|
||
|
1:30 PM PT |
Cadence Pharmaceuticals 3rd Quarter 2012 Earnings Release
|
||
|
2:40 PM ET |
Stifel Nicolaus Healthcare Conference 2012
|
||
|
|
Wedbush PACGROW Life Sciences Management Access Conference
|
||
|
1:30 PM PT |
Cadence Pharmaceuticals 2nd Quarter 2012 Earnings Release
|
||
|
3:30 PM ET |
7th Annual JMP Securities Healthcare Conference
|
||
|
2:00 PM PT |
JMP Securities 11th Annual Research Conference
|
||
|
4:50 PM ET |
Deutsche Bank Securities, Inc. 37th Annual Health Care Conference
|
||
|
1:30 PM PT |
Cadence Pharmaceuticals 1st Quarter 2012 Earnings Release
|
||
|
10:40 AM ET |
Cowen and Company 32nd Annual Health Care Conference
|
||
|
8:00 AM ET |
Leerink Swann Healthcare Conference
|
||
|
9:30 AM ET |
JMP Securities Healthcare Conference
|
||
|
11:30 AM ET |
UBS Global Life Sciences Conference
|
||
|
1:15 PM ET |
Wedbush Securities Life Science Management Access Conference
|
||
|
9:30 AM ET |
Canaccord Genuity Growth Conference
|
||
|
1:30 PM PT |
Cadence Pharmaceuticals 2nd Quarter 2011 Earnings Release
|
Important Disclaimer: The reports, presentations and/or filings of Cadence Pharmaceuticals, Inc., posted above contain time-sensitive information. The information contained therein is only accurate as of the date thereof, and Cadence will not review or update the material that is contained in these items after the data thereof. The information contained in these reports, presentations and/or filings may, however, be updated, amended, supplemented or otherwise altered by subsequent reports, presentations and/or filings by Cadence Pharmaceuticals.
| Stock Quote |
|---|
| CADX - (NASDAQ)
$6.70 - 0.29 May 22, 2013 4:00 PM ET |
Quotes delayed at
least 20 minutes.
Information provided
by eSignal.

= add file to Briefcase

